Mechanisms of Vascular Defects in Diabetes Mellitus
| Autor Corporativo: | |
|---|---|
| Otros Autores: | , , |
| Formato: | eBook |
| Lenguaje: | English |
| Publicado: |
Cham :
Springer International Publishing : Imprint: Springer,
2017.
|
| Edición: | 1st ed. 2017. |
| Colección: | Advances in Biochemistry in Health and Disease ;
17 |
| Materias: | |
| Acceso en línea: | https://doi.org/10.1007/978-3-319-60324-7 |
Tabla de Contenidos:
- Section 1 Introduction
- The Global Burden Of Diabetes And Its Vascular Complications
- SECTION 2 Pathogenesis
- Genetic Basis For Increased Risk For Vascular Diseases In Diabetes
- Vascular Remodelling In Diabetes Mellitus
- Pathogenesis Of The Plaque Vulnerability In Diabetes Mellitus
- Endothelial Dysfunction In Diabetes
- Smooth Muscle Cells In Diabetes Mellitus
- Monocytes Factors In Pathogenesis Of Vascular Lesions In Diabetes
- Endothelial Progenitor Cell Dysfunction In The Pathogenesis Of Vascular Complications Of Diabetes
- Pathogenetic mechanisms in diabetic retinopathy: from molecules to cells to tissues
- Perspectives on the vascular pathogenesis of diabetic neuropathy
- SECTION 3 Molecular mechanisms
- The Renin - Angiotensin System And Diabetes
- Adipokines And Vascular Disease In Diabetes
- G-Proteins In Vascular Complications Of Diabetes
- Histone Deacetylases In Vascular Pathophysiology: Regulation By Vasoactive Peptides And Growth Factors
- Role of non-coding RNAs in vascular complications of diabetes mellitus
- SECTION 4 Hemostatic Factors
- Diabetes As A Prothrombotic State
- Mechanisms Of Hypercoagulation And Aberrant Clot Lyses In Type 2 Diabetes
- Platelet Dysfunction In Type-2 Diabetes Mellitus
- SECTION 5 Metabolic Factors
- Advanced Glycation End Products In Diabetic Complications
- Atherogenicdyslipoproteinemia In Type 2 Diabetes Mellitus
- Vascular Remodeling: Homocysteine And Diabetes
- SECTION 6 Pharmacological Therapies
- Mechanisms Of Action Of Drugs For Treating Endothelial Dysfunction In Diabetes Mellitus
- Beneficial Effects Of Inorganic Nitrate/Nitrite On Vascular Function And Blood Pressure In Diabetes
- Myeloperoxidase (MPO): Do We Need Inhibitors?.